Latest Blog Posts Tagged "LRRK2"
May 01, 2019
Researchers from companies, academia and The Michael J. Fox Foundation met to share progress and challenges in developing therapies against the LRRK2 pathway.
March 11, 2019
A new study suggests urate may protect the genetic mutation that increases PD risk.
January 18, 2019
This is the second Foundation-sponsored study to grow crystals of the LRRK2 protein in space.
January 10, 2019
The goal is to grow high-resolution crystals of LRRK2.
November 14, 2018
The MJFF-sponsored study will attempt to grow crystals of the LRRK2 protein in microgravity conditions.
October 25, 2018
'Forbes' published a story detailing a 'milestone moment' in the history of LRRK2 and role of the Foundation in ushering this promising genetic target forward.
September 17, 2018
MJFF scientists presented and shared ideas at the Biochemical Society's Biennial International LRRK2 Meeting.
August 10, 2018
An MJFF-funded study suggests that a drug targeting the LRRK2 genetic mutation may positively impact the broader PD population.
August 02, 2018
Denali will move its drug into trials with patients with or without a LRRK2 mutation after new research points to potential widespread use of these therapies.
July 27, 2018
New findings show that Parkinson's disease patients may benefit from therapies targeting LRRK2, even if they don't have a LRRK2 gene mutation.